High-Dose Methotrexate in Patients With Lymphoma: Predictors of a Complicated Course.
O'Donoghue DF, Truong HL, Finnes HD, McDonald JS, May HP, Ansell SM, Bennani NN, Habermann TM, Inwards DJ, Johnston PB, Khurana A, Lin Y, Micallef IN, Nowakowski GS, Paludo J, Porrata LF, Thanarajasingam G, Thompson CA, Villasboas JC, Wang Y, Witzig TE, Leung N.
O'Donoghue DF, et al. Among authors: may hp.
JCO Oncol Pract. 2022 Dec;18(12):e1908-e1917. doi: 10.1200/OP.22.00182. Epub 2022 Oct 14.
JCO Oncol Pract. 2022.
PMID: 36240468